US FDA Approves Fortress Bio and Zydus’ Treatment for a Rare Pediatric Disease

by | Jan 13, 2026 | Health

The U.S. Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences’ drug for children ‌with a rare genetic disorder that impairs copper…
Reuters Health Information

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments